NCT04957719

AMI is Acute myocardial infarction

It contributes to about 9M global deaths/yr from ischemic heart disease, with each 30-minute delay in STEMI treatment increasing 1-year mortality risk by 7.5%

phase 2 data: 80% platelet inhibition within 15 minutes via subcutaneous injection, far quicker than oral antiplatelets.

The phase 3 SOS-AMI trial, started in 2021, does test selatogrel in patients with prior AMI

It’s investigational, not approved yet, but large outcome trials are underway. Early studies show rapid platelet inhibition, and the global SOS-AMI study is testing real-world outcomes.

Selatogrel auto-injector (SOS-AMI trial) is a fast-acting, subcutaneous P2Y₁₂ inhibitor designed to be self-injected at the first signs of a suspected heart attack (like chest pain), then followed by standard care.

Even people who think AI in biology is a grift (lol) cannot argue against these two.

If you think AI is a scam here, that is either a data issue or a skill issue.

The 2 simplest ways AI helps biology
- parsing multimodal data in parallel to choose the best data for a human to look at reducing inefficiency
- embed large # of signals about cells and clusters of cells to create lower-dimensional representations that are more human interpretable in the 3D/4D.

might not reflect in the stock market just yet. tens of insanely lucrative partnerships have been initiated in AI drug discovery every single year this decade

lol

[ cue someone insulting you for using the word diversify ]

In ONE WEEK it degenerated man

Diversify your portfolio! Diversify your portfolio!